Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bioanalysis|March 29, 2012
A case study on Sema3E-Fc aggregation and assay-dependent differences in quantitationDaniela Bumbaca, Raymond K Tong, Alexander W Koch, et al.
Science (New York, N.Y.)|November 21, 2015
Operational redundancy in axon guidance through the multifunctional receptor Robo3 and its ligand NELL2Alexander Jaworski, Irene Tom, Raymond K Tong, et al.
The Journal of Biological Chemistry|June 19, 2007
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sproutingQi Pan, Yvan Chathery, Yan Wu, et al.
Protein Engineering, Design & Selection : PEDS|October 7, 2017
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screeningHok Seon Kim, Diana Ronai Dunshee, Angie Yee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumorsYan Xin, Jessica Li, Jenny Wu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2010
MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma modelKent S Boles, Anne H Schmieder, Alexander W Koch, et al.
Cancer Cell|January 16, 2007
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growthQi Pan, Yvan Chanthery, Wei-Ching Liang, et al.
The Journal of Biological Chemistry|January 13, 2017
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in MiceMegan Lo, Hok Seon Kim, Raymond K Tong, et al.
Neuron|December 22, 2015
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesY Joy Yu Zuchero, Xiaocheng Chen, Nga Bien-Ly, et al.
Pageof 2